Shao, Ruosi
Neil, Jordan M.
Chen, Meng
Hannafon, Bethany
Nipp, Ryan
Montgomery, Audrey
Frank-Pearce, Summer G.
Moxley, Katherine
Richardson, Debra L.
Elliott, Jacey
Benson, Lizbeth
Gossett, Amy Gin
Businelle, Michael S.
Funding for this research was provided by:
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
Oklahoma Tobacco Settlement Endowment Trust (R21-02)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
National Cancer Institute (P30CA225520)
Article History
Received: 16 January 2025
Accepted: 16 February 2026
First Online: 20 February 2026
Declarations
:
: The study protocol was approved by the Institutional Review Board at the University of Oklahoma Health Sciences (IRB12115) in compliance with the Helsinki Declaration and registered on ClinicalTrials.gov (NCT04397614). Participants were recruited during visits to the chemotherapy infusion clinic. Eligible patients underwent screening, provided informed consent, and downloaded the app on their personal or a study-provided smartphone.
: NA.
: The authors declare no competing interests.